Risk factors
Repligen (RGEN) risk factors
Item 1A of every Repligen Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors49 risks12 new9 dropped12 reworded
Repligen added new risks regarding joint ventures, ongoing IT and inventory material weaknesses, ESG reporting, and cyber threats. The company updated financial health care disclosures to reference the OBBBA enacted in July 2025.
Filed Feb 26, 2026 - FY2024 10-K risk factors46 risks
Repligen faces intense bioprocessing competition from major players like Danaher and Thermo Fisher. Growth relies heavily on acquisitions and new product development. International operations expose the company to currency fluctuations and geopolitical risks.
Filed Mar 14, 2025